Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil A Bhowmick

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2020
Cancer epithelia-derived mitochondrial DNA is a targetable initiator of a paracrine signaling loop that confers taxane resistanceSubhash Haldar, Rajeev Mishra, Sandrine Billet, et al.
Cancers|June 10, 2023
Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic CancerHayato Muranaka, Andrew Hendifar, Arsen Osipov, et al.
Cancer Research|June 19, 2008
Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activityVeronica R Placencio, Ali-Reza Sharif-Afshar, Xiaohong Li, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|June 29, 2006
Bladder tissue formation from cultured bladder urotheliumSiam Oottamasathien, Karin Williams, Omar E Franco, et al.
Oncotarget|November 8, 2017
S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting microRNA 34a/b-methionine adenosyltransferase 2A/2B axisMaria Lauda Tomasi, Carla Cossu, Ylenia Spissu, et al.
Oncotargets and Therapy|September 23, 2021
Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient SelectionAlexis LeVee, Ching Ying Lin, Edwin Posadas, et al.
The Journal of Urology|August 30, 2008
Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urotheliumGovindaraj Anumanthan, John H Makari, Lindsey Honea, et al.
Neoplasia (New York, N.Y.)|August 21, 2012
Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancerRoger S Jackson, William Placzek, Ana Fernandez, et al.
The Journal of Urology|August 21, 2009
Bladder stromal loss of transforming growth factor receptor II decreases fibrosis after bladder obstructionGovindaraj Anumanthan, Stacy T Tanaka, Cyrus M Adams, et al.
Endocrine-Related Cancer|November 25, 2025
Radiation reprograms fibroblasts to drive prostate cancer therapy resistanceAnisha Madhav, Manish Thiruvalluvan, Frank Duong, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2020
Cancer epithelia-derived mitochondrial DNA is a targetable initiator of a paracrine signaling loop that confers taxane resistanceSubhash Haldar, Rajeev Mishra, Sandrine Billet, et al.
Cancers|June 10, 2023
Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic CancerHayato Muranaka, Andrew Hendifar, Arsen Osipov, et al.
Cancer Research|June 19, 2008
Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activityVeronica R Placencio, Ali-Reza Sharif-Afshar, Xiaohong Li, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|June 29, 2006
Bladder tissue formation from cultured bladder urotheliumSiam Oottamasathien, Karin Williams, Omar E Franco, et al.
Oncotarget|November 8, 2017
S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting microRNA 34a/b-methionine adenosyltransferase 2A/2B axisMaria Lauda Tomasi, Carla Cossu, Ylenia Spissu, et al.
Oncotargets and Therapy|September 23, 2021
Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient SelectionAlexis LeVee, Ching Ying Lin, Edwin Posadas, et al.
The Journal of Urology|August 30, 2008
Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urotheliumGovindaraj Anumanthan, John H Makari, Lindsey Honea, et al.
Neoplasia (New York, N.Y.)|August 21, 2012
Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancerRoger S Jackson, William Placzek, Ana Fernandez, et al.
The Journal of Urology|August 21, 2009
Bladder stromal loss of transforming growth factor receptor II decreases fibrosis after bladder obstructionGovindaraj Anumanthan, Stacy T Tanaka, Cyrus M Adams, et al.
Endocrine-Related Cancer|November 25, 2025
Radiation reprograms fibroblasts to drive prostate cancer therapy resistanceAnisha Madhav, Manish Thiruvalluvan, Frank Duong, et al.
Pageof 11